Cannabimovone (CBM) is a phytocannabinoid first isolated from a non-psychoactive strain of Cannabis sativa in 2010, which is thought to be a rearrangement product of cannabidiol. It lacks affinity for cannabinoid receptors, but acts as an agonist at both TRPV1 and PPARγ.
See also Cannabichromene Cannabicitran Cannabicyclol Cannabielsoin Cannabigerol Cannabinodiol Cannabisol Cannabitriol Delta-6-CBD
References